GlaxoSmithKline Pakistan Limited (PSX: GLAXO)
Pakistan
· Delayed Price · Currency is PKR 411.46
-5.41 (-1.30%)
At close: Jan 29, 2025
GlaxoSmithKline Pakistan Revenue
GlaxoSmithKline Pakistan had revenue of 14.73B PKR in the quarter ending September 30, 2024, with 6.97% growth. This brings the company's revenue in the last twelve months to 56.23B, up 15.29% year-over-year. In the year 2023, GlaxoSmithKline Pakistan had annual revenue of 49.66B with 18.69% growth.
Revenue (ttm)
56.23B
Revenue Growth
+15.29%
P/S Ratio
2.33
Revenue / Employee
33.08M
Employees
1,700
Market Cap
131.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 49.66B | 7.82B | 18.69% |
| Dec 31, 2022 | 41.84B | 5.18B | 14.13% |
| Dec 31, 2021 | 36.66B | 1.57B | 4.48% |
| Dec 31, 2020 | 35.09B | -1.49B | -4.08% |
| Dec 31, 2019 | 36.58B | 2.57B | 7.57% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Abbott Laboratories (Pakistan) | 63.81B |
| The Searle Company | 28.32B |
| AGP Limited | 23.45B |
| Highnoon Laboratories | 23.02B |
| Shifa International Hospitals | 24.67B |
| Citi Pharma | 12.93B |
| Ferozsons Laboratories | 15.96B |
| Otsuka Pakistan | 3.18B |